Literature DB >> 18282552

Ocular allergy treatment.

Leonard Bielory1.   

Abstract

Nonpharmacologic interventions are commonly used as first-line treatment of ocular allergy and include avoidance, cold compresses, lubrication, and the use of disposable daily contact lenses. Pharmacologic management of ocular allergy has increased exponentially over the past decade. Clinically available agents are being expanded to specifically address the various signs and symptoms of inflammation associated with ocular allergy. Immunotherapy has been shown to decrease the sensitivity of the eye 10 to 100 fold and may have an effect for several years after halting of immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18282552     DOI: 10.1016/j.iac.2007.12.001

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  6 in total

1.  Allergic conjunctivitis and nasal allergy.

Authors:  Zdenek Pelikan
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

2.  Glucocorticoid action in human corneal epithelial cells establishes roles for corticosteroids in wound healing and barrier function of the eye.

Authors:  Mahita Kadmiel; Agnes Janoshazi; Xiaojiang Xu; John A Cidlowski
Journal:  Exp Eye Res       Date:  2016-09-04       Impact factor: 3.467

3.  The management of ocular allergy in community pharmacies in the United Kingdom.

Authors:  Paramdeep Bilkhu; James S Wolffsohn; Deanna Taylor; Emma Gibson; Bhavik Hirani; Shehzad A Naroo
Journal:  Int J Clin Pharm       Date:  2013-01-01

4.  Intranasal corticosteroids: do they improve ocular allergy?

Authors:  Catherine Origlieri; Leonard Bielory
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

5.  Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis.

Authors:  Jeremy B Wingard; Francis S Mah
Journal:  Clin Ophthalmol       Date:  2011-02-15

6.  Neuronal FcεRIα directly mediates ocular itch via IgE-immune complex in a mouse model of allergic conjunctivitis.

Authors:  Huan Cui; Fan Liu; Yehong Fang; Tao Wang; Bo Yuan; Chao Ma
Journal:  J Neuroinflammation       Date:  2022-02-23       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.